Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of the Use of Biomarkers on Early Discontinuation of Empirical Antifungal Therapy in Critically Ill Patients: a Randomized Controlled Study.

NCT03538912 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT03538912
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03538912 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of the Use of Biomarkers on Early Discontinuation of Empirical Antifungal Therapy in Critically Ill Patients: a Randomized Controlled Study.
Lead sponsor
University Hospital, Lille
Phase
Not applicable
Overall status
Completed
Start date
June 6, 2018
Completion date
September 3, 2024
Enrollment
192 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

invasive candidiasis